BS

Bikram Sarmah

Director Director DIN 07044937
DIN 07044937 First appointment Feb 2015 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 2015
Shareholding value Locked Premium profile

About Bikram Sarmah

Bikram Sarmah has 11 years in corporate governance. Formerly with 1 company, such as Pills And Remedies Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07044937
Primary Designation Director
First Appointment 02 Feb 2015
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Pills And Remedies Private Limited U51397AS2015PTC012023
Director 02 Feb 2015 2015 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pills And Remedies Private Limited
Premium access

Shareholding and investment profile for Bikram Sarmah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bikram Sarmah

Bikram Sarmah has 11 years in corporate governance. Formerly with 1 company, such as Pills And Remedies Private Limited. Engaged in General Business. Contributes to corporate operations.

Bikram Sarmah is associated with 0 companies as a director.

Bikram Sarmah has expertise in General Business.

Bikram Sarmah has 11 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available